Works matching IS 2160763X AND DT 2016 AND VI 5 AND IP 5


Results: 11
    1
    2

    Issue Information.

    Published in:
    Clinical Pharmacology in Drug Development, 2016, v. 5, n. 5, p. 327, doi. 10.1002/cpdd.228
    Publication type:
    Article
    3
    4
    5

    Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of ASP2408, a Potent Selective T-Cell Costimulation Modulator After Single and Multiple Ascending Doses in Healthy Volunteers and RA Patients.

    Published in:
    Clinical Pharmacology in Drug Development, 2016, v. 5, n. 5, p. 408, doi. 10.1002/cpdd.251
    By:
    • Zhu, Tong;
    • Keirns, James;
    • Howieson, Corrie;
    • Kaibara, Atsunori;
    • Goldwater, Ronald;
    • Kivitz, Alan J.;
    • Chindalore, Vishala;
    • Cohen, Stanley;
    • Santos, Vicki;
    • Akinlade, Bolanle;
    • Kernstock, Robert;
    • Delgado‐Herrera, Leticia;
    • Blahunka, Paul C;
    • Karrer, Erik E.;
    • Garg, Jay P.;
    • Samberg, Nancy;
    • Zeiher, Bernhardt G.
    Publication type:
    Article
    6
    7

    A Thorough QTc Study Confirms Early Pharmacokinetics/QTc Modeling: A Supratherapeutic Dose of Omarigliptin, a Once-Weekly DPP-4 Inhibitor, Does Not Prolong the QTc Interval.

    Published in:
    Clinical Pharmacology in Drug Development, 2016, v. 5, n. 5, p. 383, doi. 10.1002/cpdd.260
    By:
    • Tatosian, Daniel A.;
    • Cardillo Marricco, Nadia;
    • Glasgow, Xiaoli Shirley;
    • DeGroot, Bruce;
    • Dunnington, Katherine;
    • George, Laura;
    • Gendrano, Isaias Noel;
    • Johnson‐Levonas, Amy O.;
    • Swearingen, Dennis;
    • Kauh, Eunkyung
    Publication type:
    Article
    8
    9
    10
    11